Oncogenes & Tumor Suppressor Antibodies focus on proteins that can drive or restrain malignant transformation. Oncogenes often promote growth, survival, invasion, or altered metabolism when activated, while tumor suppressors help maintain checkpoint control, genomic stability, apoptosis, differentiation, and normal tissue architecture.
The balance between oncogenic signaling and tumor suppressor function has broad implications for cancer initiation, progression, metastasis, and treatment response. These antibodies support detection of key regulatory proteins, altered expression patterns, pathway activation states, and molecular features that link gene function with tumor phenotype and cellular behavior.
| Terms & Conditions | Privacy Policy | Site Map |
| Copyright © EpigenTek Group Inc. All rights reserved. |